3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
7
Esophageal Neoplasms
4
Stomach Neoplasms
3
Smoking Cessation
3
Neoplasms
3
Colonic Neoplasms
3
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Pancreatic Neoplasms
1
Obesity
1
Nutrition Disorders
1
Malnutrition
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Insulin Resistance
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Frailty
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Alcohol Drinking
1
Interventions
Gemcitabine
7
Cystectomy
5
Cisplatin
5
durvalumab
4
Neoadjuvant Therapy
4
Mitomycin
4
atezolizumab
3
Transurethral Resection of Bladder
3
Nivolumab
3
Epirubicin
3
Chemoradiotherapy
3
BCG Vaccine
3
Anesthesia, Spinal
3
tislelizumab
2
disitamab vedotin
2
catumaxomab
2
Vitamin E
2
Urinary Diversion
2
Sunitinib
2
Selenium
2
Robotic Surgical Procedures
2
Multiparametric Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Fentanyl
2
Docetaxel
2
Diathermy
2
Cystoscopy
2
Chemoprevention
2
BCG Connaught
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Urinary Bladder Neoplasms
×
Preoperative Exercise
×
Clear all
NCT05480735
2022-10-31
ENHANCE
The Netherlands Cancer Institute
Phase NA
Unknown
154 enrolled